Literature DB >> 11508817

Primary Ewing's sarcoma/peripheral primitive neuroectodermal tumor at the vertex of the skull with elevated serum carcinoembryonic antigen: case report.

T Tamiya1, Y Ono, S Daido, K Tokunaga, S Hamazaki, A Kawai, T Ohmoto.   

Abstract

A primary Ewing's sarcoma arising in the skull is relatively rare. Although a small number of case reports noted elevated carcinoembryonic antigen (CEA) in patients with primary central nervous system (CNS) neoplasms, there is no report of Ewing's sarcoma/peripheral primitive neuroectodermal tumor (PNET) with elevated serum levels of CEA. A 7-year-old boy who had episodes of headache and vomiting had noticed a solid mass in the vertex of the head. Imaging studies revealed a large intra- and extracranial tumor at the vertex of the skull. Hematological examination demonstrated high serum levels of CEA: 91.09 ng/ml. The patient initially underwent an embolization of the bilateral middle meningeal arteries with Gelfoam particles. One week later, the patient was operated on and a subtotal resection of the tumor was performed. On histopathological and molecular genetic examination, the tumor was diagnosed as a Ewing's sarcoma/peripheral PNET. Immunohistochemical study showed strongly positive staining for CEA in the tumor cells. The serum level of CEA was normalized at 0.83 ng/ml after the tumor was removed and the boy underwent radiotherapy and 3 courses of chemotherapy. This is the first reported case of a primary Ewing's sarcoma/peripheral PNET at the vertex of the skull with elevated serum CEA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11508817     DOI: 10.1023/a:1010676521149

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  20 in total

Review 1.  Primary Ewing's sarcoma of the cranium.

Authors:  K I Desai; T D Nadkarni; A Goel; D P Muzumdar; K N Naresh; C N Nair
Journal:  Neurosurgery       Date:  2000-01       Impact factor: 4.654

Review 2.  The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues.

Authors:  S Hammarström
Journal:  Semin Cancer Biol       Date:  1999-04       Impact factor: 15.707

3.  Peripheral-type primitive neuroectodermal tumor arising in the tentorium. Case report.

Authors:  Y Katayama; S Kimura; T Watanabe; A Yoshino; M Koshinaga
Journal:  J Neurosurg       Date:  1999-01       Impact factor: 5.115

Review 4.  Primitive neuroectodermal tumor and Ewing's sarcoma.

Authors:  L P Dehner
Journal:  Am J Surg Pathol       Date:  1993-01       Impact factor: 6.394

5.  Pseudopsammomatous meningioma with elevated serum carcinoembryonic antigen: a true secretory meningioma. Case report.

Authors:  D N Louis; A J Hamilton; R A Sobel; R G Ojemann
Journal:  J Neurosurg       Date:  1991-01       Impact factor: 5.115

6.  Primitive neuroectodermal tumor of the median nerve. Case report with cytogenetic analysis.

Authors:  E W Akeyson; I E McCutcheon; M A Pershouse; P A Steck; G N Fuller
Journal:  J Neurosurg       Date:  1996-07       Impact factor: 5.115

7.  Carcinoembryonic antigen in patients with intracranial tumors.

Authors:  Y Suzuki; R Tanaka
Journal:  J Neurosurg       Date:  1980-09       Impact factor: 5.115

8.  Immunostaining of the p30/32MIC2 antigen and molecular detection of EWS rearrangements for the diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumor.

Authors:  K Scotlandi; M Serra; M C Manara; S Benini; M Sarti; D Maurici; P L Lollini; P Picci; F Bertoni; N Baldini
Journal:  Hum Pathol       Date:  1996-04       Impact factor: 3.466

9.  Carcinoembryonic antigen production associated with an osteolytic meningioma. Case report.

Authors:  M D Partington; B W Scheithauer; D G Piepgras
Journal:  J Neurosurg       Date:  1995-03       Impact factor: 5.115

10.  DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES.

Authors:  P GOLD; S O FREEDMAN
Journal:  J Exp Med       Date:  1965-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.